[ad_1]
After the vaccine developed by BioNTech and Pfizer, the US-based Moderna also announced that the Covid-19 vaccine developed was effective.
In the statement made by Moderna, it was stated that the vaccine had a protective effect of 94.5 percent according to the results of the third phase.
The vaccine developed by Pfizer with BioNTech, led by Turkish scientists Uğur Şahin and Özlem Türeci, also had a 90 percent protective effect.
THE EUROPEAN PHARMACEUTICAL AGENCY STARTED THE VACCINE
In the statement made by the European Medicines Agency (EMA), it was reported that the American biotechnology company Moderna has examined the “MRNA-1273” vaccine developed against Covid-19. In the statement, it was stated that the decision was made after the first results showed that the vaccine examination triggered the production of antibodies and T cells targeting the corona virus in the body.
It was stated that the over-examination committee began to evaluate the preclinical data and it was emphasized that it is hoped to begin reviewing the clinical trial data after the results obtained.
It was indicated that all available data on the safety and quality of the vaccine (such as the method of production and storage conditions) will be reviewed. Moderna CEO Stephane Bancel said in a statement: “We will continue our dialogue with the EMA as we try to develop a safe and effective vaccine.”
AVAILABLE SPRING 2021
Moderna CEO Stephane Bancel announced that several million doses of the corona virus vaccine have been produced in the US.
British officials also announced that the corona virus vaccine developed by Moderna has vetted the supply chain in Europe and that doses can be distributed in spring 2021.
It may interest you
It may interest you
[ad_2]
